Webhaber
This under-the-radar biotech stock is an overlooked buying opportunity that could almost double, UBS says

This under-the-radar biotech stock is an overlooked buying opportunity that could almost double, UBS says

The stock has surged more than 50% in 2023 alone, but one analyst expects the German company has further to climb.

Cnbc Cnbc | Go to detail of news source

Cnbc, Benzer haberler

Cnbc Pinterest jumps on better-than-expected third-quarter results Pinterest jumps on better-than-expected third-quarter results
Cnbc How Tesla's price cuts could spur an EV pricing war How Tesla's price cuts could spur an EV pricing war
Cnbc Jefferies upgrades Philip Morris, says shares can rise nearly 20% on smokeless alternatives Jefferies upgrades Philip Morris, says shares can rise nearly 20% on smokeless alternatives
Cnbc Floods devastate Philippines as president declares 'state of calamity' Floods devastate Philippines as president declares 'state of calamity'
Cnbc Winners and losers of the UAW talks with GM, Ford and Stellantis Winners and losers of the UAW talks with GM, Ford and Stellantis
Cnbc Meta acquisition of Within reportedly approved by court in loss for FTC Meta acquisition of Within reportedly approved by court in loss for FTC